Scott Terrillion - Mar 3, 2022 Form 4 Insider Report for Cara Therapeutics, Inc. (CARA)

Role: Sec'y; Chief Compliance & G.C.
Signature: /s/ Darren DeStefano, Attorney-in-Fact
Stock symbol: CARA
Transactions as of: Mar 3, 2022
Transactions value $: -$20,336
Form type: 4
Date filed: 3/4/2022, 04:51 PM
Previous filing: Mar 1, 2022
Next filing: Apr 5, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CARA	Common Stock	Sale	-$20.3K	-1.79K	-1.69%	$11.38	104K	Mar 3, 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This sale was effected pursuant to a "sell to cover" arrangement adopted by the Reporting Person in accordance with Rule 10b5-1 on September 6, 2018 to satisfy the tax withholding obligations triggered by the vesting of performance-based RSUs reported in the Form 4 filed with the Securities and Exchange Commission on March 1, 2022, and does not represent a discretionary trade by the Reporting Person.

Content

This sale was effected pursuant to a "sell to cover" arrangement adopted by the Reporting Person in accordance with Rule 10b5-1 on September 6, 2018 to satisfy the tax withholding obligations triggered by the vesting of performance-based RSUs reported in the Form 4 filed with the Securities and Exchange Commission on March 1, 2022, and does not represent a discretionary trade by the Reporting Person.